Presynaptic Molecular Determinants of Quantal Size by Shigeo Takamori
REVIEW
published: 08 February 2016
doi: 10.3389/fnsyn.2016.00002
Presynaptic Molecular Determinants
of Quantal Size
Shigeo Takamori*
Laboratory of Neural Membrane Biology, Graduate School of Brain Science, Doshisha University, Kyoto, Japan
Edited by:
Silvio O. Rizzoli,
University Medical Center Göttingen,
Germany
Reviewed by:
Christian Lohmann,
Netherlands Institute for
Neuroscience, Netherlands
Volker Haucke,
Freie Universität Berlin, Germany
*Correspondence:
Shigeo Takamori
stakamor@mail.doshisha.ac.jp
Received: 09 November 2015
Accepted: 25 January 2016
Published: 08 February 2016
Citation:
Takamori S (2016) Presynaptic
Molecular Determinants of
Quantal Size.
Front. Synaptic Neurosci. 8:2.
doi: 10.3389/fnsyn.2016.00002
The quantal hypothesis for the release of neurotransmitters at the chemical synapse
has gained wide acceptance since it was first worked out at the motor endplate
in frog skeletal muscle in the 1950’s. Considering the morphological identification of
synaptic vesicles (SVs) at the nerve terminals that appeared to be homogeneous
in size, the hypothesis proposed that signal transduction at synapses is mediated
by the release of neurotransmitters packed in SVs that are individually uniform in
size; the amount of transmitter in a synaptic vesicle is called a quantum. Although
quantal size—the amplitude of the postsynaptic response elicited by the release of
neurotransmitters from a single vesicle—clearly depends on the number and sensitivity
of the postsynaptic receptors, accumulating evidence has also indicated that the amount
of neurotransmitters stored in SVs can be altered by various presynaptic factors.
Here, I provide an overview of the concepts and underlying presynaptic molecular
underpinnings that may regulate quantal size.
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INTRODUCTION
Synaptic transmission requires the release of neurotransmitters from presynaptic terminals.
Since the pioneering work by Katz and colleagues in the frog neuromuscular junction and
the morphological identification of synaptic vesicles (SVs) of apparently homogeneous size at
presynaptic terminals by electron microscopy, neurotransmitters have been believed to be packed
in SVs and released from them as discrete and uniform ‘‘quanta’’. However, emerging evidence has
suggested that quantal response, which is a postsynaptic current elicited by the fusion of a single
vesicle, in the mammalian central nervous system (CNS) exhibits a certain degree of variation.
Because postsynaptic receptors at mammalian glutamatergic synapses are not usually saturated
by release of neurotransmitters from a single SV, possible sources of the variations in quanta are
presynaptic. In fact, detailed investigations at central glutamatergic synapses called the calyx of
Held have revealed that the vesicular glutamate concentration is a plausible source of quantal
variations (Wu et al., 2007). In this review, I will introduce our current molecular knowledge and
the possible presynaptic determinants responsible for the regulation of quantal size.
MINIMAL MOLECULAR COMPLEXES FOR THE FORMATION
OF QUANTUM IN SVs
Neurotransmitters are usually synthesized in the presynaptic cytoplasm and are concentrated
into SVs by the activity of vesicular transporters specific for the respective neurotransmitters.
All known vesicular transporters responsible for neurotransmitter uptake into SVs utilize
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a proton electrochemical gradient (∆µH+) generated by
the vacuolar-type H+ ATPase (V-ATPase). The V-ATPase
consists of at least 13 subunits with a total molecular weight of
∼800 kDa and represents the largest molecular complex on SVs.
The V-ATPase is divided into two functionally distinct portions.
The V1 part consists of one large transmembrane protein (a1
subunit) in association with several globular A and B subunits
and catalyzes ATP hydrolysis, releasing energy for proton
transfer. The V0 part forms a ring-like structure in themembrane
and provides a proton permeation pathway. By transferring
protons into the SV lumen, the V-ATPase generates both a
pH gradient (∆pH) and a membrane potential (inside positive
voltage referred to ∆9) across the SV membrane. The vesicular
transporters for classical neurotransmitters utilize ∆pH, ∆9 ,
or both, depending on the neurotransmitter type. Five classes
of vesicular transporters have been cloned and molecularly
characterized so far, including two vesicular monoamine
transporters (VMAT1, VMAT2), vesicular acetylcholine
transporter (VAChT), three vesicular glutamate transporters
(VGLUT1–3), vesicular GABA/glycine transporter (VGAT;
also referred to as vesicular inhibitory amino acid transporter,
VIAAT; Edwards, 2007), and vesicular nucleotide transporter
(VNUT; Sawada et al., 2008). Biochemical assays using isolated
vesicles in the presence of compounds that selectively dissipate
either ∆pH or ∆9 revealed energy requirements for their
uptake. The uptake of cationic transmitters such as acetylcholine
and biogenic amines largely depends on ∆pH, whereas that
of anionic transmitters such as glutamate predominantly
depends on ∆9 . The uptake of zwitterionic and therefore
neutral transmitters such as GABA and glycine depends on both
∆pH and ∆9 . Despite extensive studies on the bioenergetics
of the transport process, the details of the mechanisms of
transport, especially how H+ differentially drives transport of
different neurotransmitters, remain enigmatic. In addition to
neurotransmitter transporters and the V-ATPase, potential
modulators that may alter the driving force for neurotransmitter
uptake also play a role, including ion channels/transporters on
SVs (Figure 1). In this review, I will introduce key components
that underlie the formation and regulation of quanta with a
special focus on glutamate and GABA, the major excitatory
and inhibitory neurotransmitters in the mammalian CNS,
respectively.
EXPRESSION LEVEL OF THE
TRANSPORTERS
Intuitively, we expect that expression of transporter proteins
on a SV will affect the rate of transport rather than the
amount of transmitters at equilibrium. However, overexpression
of vesicular transporters in primary cultured neurons and in vivo
in fruit fly embryos as well as other model systems such as
PC12 cells results in an increase in neurotransmitter content
in individual vesicles (Pothos et al., 2000; Daniels et al., 2004;
Wojcik et al., 2004; Wilson et al., 2005; Table 1). In some
cases, enlargement of vesicles is associated with an increase
in quantal size (Daniels et al., 2004), although it is unknown
whether this can be explained simply by swelling of the vesicles
FIGURE 1 | Schematic diagram of possible elements influencing ∆µH+
and quantal size. (1) Vacuolar-type H+ ATPase (V-ATPase), which drives
neurotransmitter transport into SVs. ATP concentrations affect the
proton-transporting activity. (2) ClC-type Cl− channel family. Some ClC
isoforms operate as a 2Cl−/H+ exchanger. This stoichiometry seems to
alkalize the vesicle lumen, but may also dissipate ∆9, thereby facilitating
∆pH. (3) A putative Cl− channel. This provides a shunting current for H+,
leading to acidification. The molecular identity of the Cl− conductance has yet
to be determined. (4) Vesicular neurotransmitter transporters. Their expression
levels affect quantal size. How transporters are activated by H+ and how Cl−
modulates the transport remain obscure. (5) Cation/H+ exchanger. This
activity potentially dissipates ∆pH and facilitates ∆9, leading to an increase in
∆9-driven glutamate transport. (6) Divalent cation/H+ exchanger. This activity
plays essentially the same role as (5). The molecular identity and physiological
relevance of the system remain unknown. (7) Luminal buffers (symbolized by
green circle). The buffering capacity of the lumen conferred by intrinsic
proteins, lipids, and the intravesicular solution affects the formation of ∆pH
(presumably also ∆9), thereby influencing quantal size.
due to alterations in osmolality or if insertion of phospholipids
into the vesicles is also involved. In contrast to this view,
analyses of VGLUT heterozygous mice revealed somewhat
conflicting results. Suppression of VGLUT1 in hippocampal
neurons derived from VGLUT1+/− mice does not produce
a significant reduction in miniature excitatory postsynaptic
currents (mEPSC; Fremeau et al., 2004; Wojcik et al., 2004),
whereas VGLUT2+/− neurons that originate from the striatum
exhibit reduced mEPSCs (Moechars et al., 2006). Nevertheless,
because each SV contains ∼10 copies of VGLUT, a robust
change in expression levels may be necessary to induce detectable
changes in quantal size (Takamori et al., 2006).
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TABLE 1 | Gene manipulations of vesicular transporters/channels influence quantal size.
Gene Manipulation Preparation Quantal size Reference
VGLUT1 Overexpression Mouse hippocampal culture Glu ↑ Wilson et al. (2005) and
Wojcik et al. (2004)
Heterozygous Mouse hippocampal culture Glu→ Wojcik et al. (2004) and
Fremeau et al. (2004)
Knockout Mouse hippocampal culture Glu ↓ Wojcik et al. (2004)
Knockout Mouse hippocampal culture Glu→ Fremeau et al. (2004)
VGLUT2 Heterozygous Mouse striatal culture Glu ↓ Moechars et al. (2006)
Knockout Mouse striatal culture Glu ↓ Moechars et al. (2006)
DVGLUT∗ Mutants Neuromuscular junction Glu→ or zero Daniels et al. (2006)
Overexpression# Neuromuscular junction Glu ↑ Daniels et al. (2004)
VGAT Heterozygous Mouse striatal culture GABA→ Wojcik et al. (2006)
Knockout Mouse striatal culture GABA ↓ Wojcik et al. (2006)
VMAT2 Overexpression# Rat ventral midbrain culture Dopamine ↑ Pothos et al. (2000)
ClC-3 Knockout Acute hippocampal slice Glu→, GABA→ Stobrawa et al. (2001)
Knockout Acute hippocampal slice GABA ↓ Riazanski et al. (2011)
Knockout# Hippocampal culture Glu ↑ Guzman et al. (2014)
∗DVGLUT stands for drosophila VGLUT. Glu stands for glutamate. #Enlargement of vesicles were observed by electron microscopy.
Is the expression of vesicular neurotransmitter transporters
regulated in physiological or pathological conditions? Several
lines of evidence have suggested that this is the case.
First, VGLUT1 and VGLUT2 were originally identified as
genes that are up-regulated upon stimulation in neurons
and endocrine cell lines (Ni et al., 1994; Aihara et al.,
2000). Second, VGLUT1 expression is developmentally up-
regulated, which seems to be accompanied by an increase
in mEPSCs (De Gois et al., 2005; Yamashita et al., 2009).
Third, expression of VGLUT1, VGLUT2, and VGAT in
cultured hippocampal neurons is altered by manipulations
that change neural activities, i.e., exposure to tetrodotoxin and
antagonists for the respective neurotransmitter receptors
(De Gois et al., 2005). Fourth, VGLUT3 expression in
some brain regions is very transient, resulting in biphasic
expression profiles (Gras et al., 2005). Finally, in addition
to the total expression levels, the extent of VGLUT sorting
to the plasma membrane may regulate the vesicular level
of VGLUT proteins, which oscillate during light/dark
cycles (Darna et al., 2009). Collectively, these observations
suggest that temporal regulation of expression of vesicular
transporters for neurotransmitters scales and shapes
synaptic transmission and thus network activity in the
brain.
REGULATION OF THE PROTON
ELECTROCHEMICAL GRADIENT
ATP
Although little is known about regulation of V-ATPase
activity in vivo, several factors affect the activity, and
therefore, neurotransmitter uptake. First, cytoplasmic ATP
concentrations may be a key factor in regulation. In isolated
SVs, glutamate uptake reaches a plateau with 2 mM ATP,
which also requires Mg2+ in low mM concentrations (Naito
and Ueda, 1985). The cytoplasmic ATP concentration in the
presynaptic terminals of rat hippocampal cultured neurons
is ∼2 mM in resting conditions. During neural activity,
as cytoplasmic ATP is rapidly consumed mainly by the
process of endocytosis, ATP concentrations decrease to
∼1 mM during repetitive stimulations (Rangaraju et al.,
2014). Therefore, the physiological concentration range
of ATP may impact the activity of V-ATPase, which in
turn alters the kinetics and/or extent of glutamate refilling
of SVs. Furthermore, in some pathological conditions
such as anoxia, hypoglycemia, and ischemia, dramatic
ATP breakdown may occur, leading to reductions in
V-ATPase activity and neurotransmitter refilling (Santos
et al., 1996).
Cl− Channel
V-ATPase is an electrogenic pump, and therefore, the pump
does not transport much H+ unless counter-ion movements
across the SV membrane are present that abolish the voltage
due to the H+ flux (Moriyama and Nelson, 1987). Studies with
biochemical assays using acridine orange as a pH gradient
indicator have shown that membrane-permeable Cl− confers
a shunting current for the H+ movement, which inhibits the
formation of ∆9 , and in turn, promotes the pH gradient
(Maycox et al., 1988; Cidon and Sihra, 1989; Tabb et al., 1992).
Accordingly, with high extravesicular (cytosolic) Cl−, uptake
of cationic neurotransmitters is maximal because ∆pH is
large, whereas glutamate uptake, which is driven primarily by
∆9 , is minimal (Hell et al., 1990). Interestingly, glutamate
uptake in the absence of Cl−, where ∆9 is maximal, does
not show the highest activity (Naito and Ueda, 1985), leading
to the hypothesis that Cl− allosterically activates VGLUTs
(Hartinger and Jahn, 1993; Wolosker et al., 1996; see also
below); however, contributions of ∆pH or low luminal pH
have also been suggested (Tabb et al., 1992; Bellocchio et al.,
2000; Schenck et al., 2009). Consistent with biochemical
assays with isolated SVs in which the highest glutamate
transport is observed in the presence of a Cl− concentration
in the range of ∼10 mM, efficient glutamate refilling of SVs
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assessed in the calyx of Held synapses requires 5–30 mM
cytosolic Cl− (Hori and Takahashi, 2012). GABA uptake also
exhibits biphasic Cl− dependance, albeit to a lesser extent
(Hell et al., 1990). Although GABAergic SVs also contain Cl−
channel activity (Takamori et al., 2000), the contributions
of the channel activity to GABA transport have not been
clarified.
The molecular identity of the putative Cl− channel on
SVs has not been firmly established. One member of the
ClC chloride channel family, ClC-3, is localized in SVs,
and the SV fraction derived from ClC-3−/− mice shows
a reduced Cl−-induced acidification, suggesting that ClC-3
is the Cl− channel on SVs (Stobrawa et al., 2001). In
addition, however, both glutamate-induced acidification and
glutamate transport activity are dramatically reduced in ClC-
3-deficient SV fractions (Note that if ClC-3 were the Cl−
channel on SVs, the absence of ClC-3 would result in
a reduction in ∆pH, leading an increase in glutamate
transport). These phenotypes are associated with a reduction
in VGLUT1 protein expression, which may be due to the
severe neurodegeneration of the ClC-3−/− brain, including
total loss of the hippocampus. Contrary to these biochemical
experiments, electrochemical assessments of mEPSCs (and also
miniature inhibitory postsynaptic currents, mIPSCs) in acute
hippocampal slices from ClC-3−/− mice did not show significant
changes compared to wild-type preparations. More recently, the
contribution of ClC-3 to glutamatergic neurotransmission was
challenged by using cultured hippocampal neurons established
from postnatal day 1 mice to avoid alterations in neuronal
functions due to neurodegeneration (Guzman et al., 2014).
In this preparation, both mEPSCs and evoked EPSCs were
increased in ClC-3−/− neurons, supporting the proposal
that ClC-3 contributes to SV acidification. Loss of ClC-3
produces additional phenotypes including an increased release
probability and an enlargement of SVs, suggesting multiple
roles for ClC-3 in presynaptic physiology. Furthermore,
contrary to the original report by Stobrawa et al. (2001),
ClC-3 may also contribute to GABA transport into SVs.
mIPSCs recorded from hippocampal CA1 pyramidal neurons
from ClC-3−/− mice have lower amplitudes than those
from wild-type mice (Riazanski et al., 2011). Further studies
will be necessary to clarify these contradictory results (see
Table 1).
An alternative candidate for the Cl− channel on glutamatergic
SVs is VGLUTs themselves. When SV fractions derived from
VGLUT1−/− mice were examined in an acidification assay, a
drastic reduction in Cl−-induced acidification was observed both
in 3- and 8-week-old mice. In contrast, acidification of SVs
derived from 3-week-old ClC-3−/− mice is not significantly
different from that of SVs derived from wild-type mice,
indicating that the acidification deficit observed in adult
ClC-3−/− mice is due to the massive neurodegeneration of
the VGLUT1-expressing region (Schenck et al., 2009). The
Cl−-induced acidification can also be functionally reconstituted
in proteoliposomes only when recombinant VGLUT1 protein
is included (Schenck et al., 2009; Preobraschenski et al.,
2014). An unanswered question is whether one of the two
proteins or both is responsible for the Cl− permeation
pathway in SVs.
Cation/H+ Exchanger
A proteomic study of purified SVs identified a Na+/H+
exchanger (Grønborg et al., 2010), and addition of a high
concentration of Na+ as well as K+ decreases ∆pH and
increases ∆9 as intravesicular H+ is exchanged by K+ or Na+,
providing favorable conditions for glutamate transport (Goh
et al., 2011). Furthermore, replacing cytoplasmic K+ with a
non-permeable cation attenuates the quantal size recorded from
the calyx of Held synapses. Also, increasing the presynaptic
Na+ concentration facilitates the mEPSC amplitude (Huang
and Trussell, 2014), indicating physiological significance for
the cation/H+ exchange in regulating quantal size. In the
case of Na+, presynaptic hyperpolarization-activated cyclic
nucleotide-gated (HCN) channels may play an important role
in controlling the presynaptic Na+ concentration. Intriguingly,
VGLUTs themselves may confer Na+/H+ exchanger activity
when reconstituted in liposomes, although direct evidence for
the movement of monovalent cations through VGLUTs is still
lacking (Preobraschenski et al., 2014).
Ca2+/H+ Antiport
In analogy to the role of monovalent cations in the regulation of
∆µH+, the existence of a putative Ca2+/H+ antiport system in
SVs was demonstrated by using isolated SVs (Gonçalves et al.,
1998). Addition of Ca2+ (∼600 µM) causes a slight reduction
in acidification as monitored by acridine orange, indicating
H+ efflux associated with Ca2+ influx (Gonçalves et al.,
1999). In an independent experiment, ATP-dependent 45Ca2+
transport into SVs was also demonstrated. Other divalent cations
such as Zn2+ and Cd2+ also reduce acidification, albeit with
higher efficiency. Because both Zn2+ and Cd2+ attenuate ATP-
dependent Ca2+ uptake in a concentration-dependent manner, a
common transporter may share the substrates (Gonçalves et al.,
1999). Because glutamate uptake is predominantly driven by
∆9 , the Ca2+/H+ antiport was expected to increase glutamate
uptake by converting ∆pH to ∆9 . However, the effect of Ca2+
on glutamate uptake depends on external Cl− concentrations,
indicating a complex interplay among ∆pH, ∆9 , and Cl−-
dependent activation of VGLUTs (Gonçalves et al., 2001).
Interestingly, Ca2+-induced ‘‘de-acidification’’ is decreased when
the Ca2+ sensor protein, synaptotagmin 1, is knocked down in
PC12 cells (Cordeiro et al., 2013). The precise mechanisms and
physiological relevance in SVs are poorly understood.
Luminal Buffers
Because SVs are recycled at presynaptic terminals, and newly
endocytosed SVs may engulf extracellular solution, the ionic
composition as well as the buffering strength of the extracellular
solution may impact the formation of ∆µH+. In cultured
hippocampal neurons expressing synaptopHluorin (a luminal
pH sensor), application of 100 mM Tris buffer strongly inhibits
re-acidification of newly endocytosed SVs (Ertunc et al., 2007),
although the effect on the ∆9 component remains unclear.
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Even with lower buffer concentrations, i.e., 15 mM, short-
term depression is facilitated, indicating that neurotransmitter
refilling is suppressed when a solution with a high buffering
capacity is incorporated into SVs during recycling. This was
clearly observed when evoked IPSCs were recorded from CA1
pyramidal neurons in an acute hippocampal slice preparation in
the presence of 50 mM Tris. Thus, the buffering strength of the
extracellular solution critically affects ∆pH (and probably also
∆9), leading to alteration of quantal size.
Another source of luminal H+ buffer may be intrinsic
membrane proteins and lipids that cover the luminal surface of
SVs. A recent study estimated that the SV lumen in cultured
hippocampal neurons confers relatively high buffering capacity
(56mM/pH) that requires∼1200H+ influx into a SV to establish
a ∆pH of 1.8 (Egashira et al., 2015). Because neurotransmitter
content and the intravesicular solution (which may be equivalent
to the extracellular bath solution) should not contribute much
to the luminal buffering capacity, the luminal domains of the
intrinsic membrane proteins are likely the acceptor for protons,
in good agreement with the extremely high protein density in
SVs (Takamori et al., 2006). Although activity-dependent or
homeostatic alterations in expression levels of vesicle proteins
have often been demonstrated (De Gois et al., 2005; Wilson et al.,
2005), possible contributions of these changes in protein levels to
regulation of the V-ATPase activity and the quantal size have not
been considered.
VESICULAR SYNERGY
Identification of the proton-driven neurotransmitter
transporters and the characterization of their localizations in the
nervous system have revealed that some of them are co-expressed
in the same presynaptic terminals and even on the same vesicles.
In particular, VGLUT3 is expressed in subsets of neurons that
had not been considered to be glutamatergic neurons, including
GABAergic interneurons in the hippocampus, amacrine cells in
the retina, and cholinergic neurons in the striatum (Fremeau
et al., 2002; Gras et al., 2002). Furthermore, VGLUT2 is also
present in a subpopulation of striatum dopaminergic neurons
as well as cultured dopaminergic neurons and contributes to
co-release of dopamine and glutamate from the same neurons
(Dal Bo et al., 2004, 2008).
In addition to enabling co-release of glutamate with other
transmitters, evidence is emerging that suggests that the
expression of VGLUTs facilitates the transport of other cationic
transmitters. For instance, vesicular transport of glutamate
results in increased acetylcholine transport in vesicles isolated
from the striatum, and this facilitation is diminished in
VGLUT3−/− mice (Gras et al., 2008). Moreover, analysis of
the hippocampus and prelimbic cortex from VGLUT2−/− mice
demonstrated that glutamate transport into VMAT2-carrying
SVs stimulates transport of serotonin (Hnasko et al., 2010).
Such synergistic effects of glutamate transport on the uptake
of other neurotransmitters were named ‘‘vesicular synergy’’ (see
El Mestikawy et al., 2011). Vesicular synergy was also shown
for GABA uptake in the presence of glutamate in isolated
vesicles (Zander et al., 2010), but such ‘‘vesicular synergy’’ in
neurons co-releasing glutamate and GABA turned out to be
unlikely, at least in some experimental conditions (Case et al.,
2014; Zimmermann et al., 2015). Nevertheless, these distinct
synergistic effects of glutamate co-transport on refilling of other
transmitters may involve VGLUT-dependent acidification of
SVs. In the presence of VGLUTs, both glutamate transport
and Cl− influx through VGLUT facilitates vesicle acidification
(Maycox et al., 1988; Schenck et al., 2009). Transport of cationic
transmitters may be more sensitive to acidification than that of
GABA, because transport of cationic transmitters is primarily
driven by ∆pH. Conversely, transport of cationic transmitters
may prevent efficient glutamate transport into the same SVs.
Because transport of cationic transmitters involves net efflux
of one positive charge with the proposed stoichiometry of the
substrate of H+ = 1:2 (Nguyen et al., 1998), consequent reduction
of∆9 may attenuate glutamate transport.
ALLOSTERIC REGULATION OF THE
TRANSPORTER ACTIVITY
In addition to the observation that Cl− ions affect the proton
electrochemical gradient and in turn influence neurotransmitter
uptake into SVs, Cl− may directly modulate transporter activity.
This concept was originally suggested from biochemical data
showing that DIDS, a non-selective Cl− channel blocker, inhibits
Cl−-induced acidification and glutamate-induced acidification
with different IC50 values (Hartinger and Jahn, 1993), leading
to the hypothesis that DIDS may directly bind to VGLUT
and inhibit its activity. The hypothesis could explain why
glutamate uptake is low in the absence of external Cl− where
∆9 , the primary driving force for the transport, is maximal.
Furthermore, ∆9-driven glutamate transport by reconstituted
VGLUTs requires a Cl− concentration of several mM, suggesting
that VGLUTs are the Cl−-activated glutamate uniporter (Juge
et al., 2010), although reconstitution of VGLUT with a proton
pump suggested a contradictory conclusion (Schenck et al., 2009;
Preobraschenski et al., 2014). A similar approach investigating
the role of VGAT demonstrated that although GABA transport
also requires Cl−, VGAT operates as a GABA/Cl− co-transporter
that is solely driven by∆9 (Juge et al., 2009).
CYTOSOLIC FACTORS
Neurotransmitter Concentrations
Biochemical transport assays using SV fractions purified
from native brains indicated that the transport process obeys
Michaelis-Menten kinetics describing authentic enzymatic
reactions (Naito and Ueda, 1985; Maycox et al., 1988).
With this analogy, the velocity and extent of transport
critically depends on the substrate concentrations, where
greater and faster transport occurs with higher concentrations.
Furthermore, like other protein-mediated transport pathways,
neurotransmitter uptake into SVs is substrate saturable.
In the case of glutamate uptake into isolated SVs, Km was
measured to be ∼1 mM (Naito and Ueda, 1985; Maycox
et al., 1988), meaning that the transport system becomes
saturated with >2 mM cytoplasmic glutamate. Heterologous
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expression of VGLUT1-3 in non-glutamate-releasing cells
confers similar, if not completely identical, affinity for glutamate
uptake into isolated vesicles (Kaneko and Fujiyama, 2002;
Takamori, 2006). The dependance of glutamate uptake on
cytoplasmic glutamate concentrations was further confirmed
in the calyx of Held synapses, where presynaptic cytoplasmic
glutamate concentrations can be manipulated with a glass
pipet at the presynaptic terminals. Interestingly, Ishikawa
et al. (2002) loaded the presynaptic terminal with 100 mM
glutamate and detected a dramatic increase in average mEPSC
amplitudes by >50%, confirming that the concentration of
cytoplasmic glutamate affects vesicular glutamate content.
Of note, because a glutamate concentration of 100 mM
may be extremely supra-physiological and may saturate
the VGLUT-mediated glutamate transport, a portion of
the increase in mEPSC amplitudes may be due to passive
glutamate influx through VGLUT or other non-specific
pathways.
From where is the neurotransmitter glutamate derived and
how is it regulated? Because SVs contain large amounts of
neurotransmitters, the mechanism for replenishing released
transmitters at high rates of firing must be present at the
presynaptic terminals. Classically, the glutamate-glutamine cycle
is believed to serve as the major source of the neurotransmitter
glutamate (for a review, see Chaudhry et al., 2002). In this
cycle, glutamate released from the presynaptic terminals is
taken up by the plasma membrane glutamate transporters
that are mainly located on the surface of surrounding
glial cells. Glutamate is then converted to glutamine by
glutaminase. Glutamine is released by the system N transporter
(SN1) and then is transported into the presynaptic terminal
by the system A transporter (SAT1). Finally, glutamine is
converted to glutamate by phosphate-activated glutaminase
(PAG also referred as GLS1) at the presynaptic terminal.
Although alterations in any step in the cycle would potentially
affect the concentration of presynaptic glutamate, the rate-
limiting steps have not been determined. However, despite
the long-standing notion that the conversion of glutamine
to glutamate is the major source of the neurotransmitter
glutamate, surprisingly subtle deficits on basal glutamate
transmission are seen in GLS1 knockout mice. Although
the amplitude of evoked EPSCs decays more rapidly during
a long train stimulation, mEPSC amplitude and duration
are quite normal in GLS1-null neurons, indicating that the
conversion of glutamine to glutamate in the presynaptic
terminal is not an indispensable source of the neurotransmitter
glutamate (Masson et al., 2006). Alternatively, α-ketoglutarate
has recently been proposed as a precursor of glutamate. In
fact, isolated SVs from rat brains can synthesize glutamate
from α-ketoglutarate by aminotransferase in which L-aspartic
acid specifically acts as an amino group donor. Therefore,
enzymes involved in this pathway could potentially affect
glutamate levels in the presynaptic cytosol (Takeda et al.,
2012).
The synthetic pathway of GABA clearly involves the
conversion of glutamic acid to GABA and is mediated by
two glutamic acid decarboxylases (GAD65 and GAD67),
because only trace amounts of GABA are detected in
GAD65/GAD67 double knockout mouse brain (Ji et al.,
1999). Consistent with this, administration of glutamate or
glutamine, both of which are precursors of GABA, in cultured
hippocampal neurons effectively prevents rundown of GABA
transmission during recordings. Furthermore, exposure of
cultured hippocampal neurons to excess concentrations of
glutamine facilitates IPSCs, indicating that cytosolic GABA
concentrations control vesicular GABA content (Wang et al.,
2013). Recently, another non-canonical GABA synthesis
pathway was discovered in midbrain dopaminergic neurons
(Kim et al., 2015). This type of neuron co-releases dopamine
and GABA, but GABA release does not require GABA
synthesis by GAD65 and GAD67. Instead, these neurons
use aldehyde dehydrogenase (ALDH1a1) to produce GABA
from putrescine, which is an evolutionarily conserved
pathway for the production of GABA that is also present
in plants, Xenopus, and mammalian cells (see Kim et al.,
2015). Interestingly, provided that mutations in ALDH1a1
have been linked to alcoholism in humans (Liu et al., 2011),
deletion of ALDH1a1 in mice not only attenuates GABA
co-release but also causes behavioral effects including
increased EtOH consumption and preference of EtOH
over daily water in mice, implying that diminished GABA
co-release due to an insufficient GABA supply is linked to
alcoholism.
Trimeric G Proteins
Experiments using isolated SVs demonstrated that glutamate
uptake is inhibited by the G-protein activator GMP-P(NH)P
(Pahner et al., 2003). Kinetic experiments suggested that
the inhibitor decreases both Vmax and Km of glutamate
uptake. Analyses of isolated SVs derived from mice lacking
Gαo1, Gαo2, Gαq, or Gα11 have demonstrated that Gαo2
is responsible for inhibition of glutamate uptake (Winter
et al., 2005). SVs lacking Gαo2 exhibit normal Cl−-induced
acidification, but have lost their Cl− dependency for glutamate
transport activities, indicating that Gαo2 may modulate allosteric
activation of VGLUTs by Cl−. In the case of monoaminergic
vesicles, the intravesicular monoamine concentration in
the lumen may trigger G-protein activation (Höltje et al.,
2003), providing an inhibitory feedback loop that down-
regulates transporter activity when the vesicle is full. Currently,
whether the same mechanism exists in glutamatergic vesicles
is not clear, and if so, what types of signals, i.e., glutamate
itself, protons, or other unknown factors, transfer such
a signal from the lumen to the cytoplasmic side is also
unknown.
Other Factors
Besides the G proteins described above, we know little
about endogenous cytoplasmic proteins that could regulate
neurotransmitter uptake into SVs. Ueda and colleagues purified
cytosolic proteins from bovine brains. These proteins inhibit
uptake of both glutamate and GABA and were named inhibitory
protein factor (IPF) αβγ (Ozkan et al., 1997). IPF appears
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to contain the amino acid sequence of the α subunit of
the cytoskeletal protein fodrin, but fodrin itself does inhibit
glutamate transport (Tamura et al., 2001). Themolecular identity
and physiological relevance of the function of IPFs remain to be
elucidated.
CONCLUDING REMARKS
Over the past several decades, presynaptic molecular
components that regulate the quantal size have emerged.
Because the amount of neurotransmitters in single vesicles
may influence both spontaneous and evoked synaptic
transmission, changes in quantal size may have a strong
impact on brain functions including cognition, learning
and memory, and behavior. Despite intensive research, we
know little about the mechanisms and the rate-limiting
steps underlying the formation of quanta. In particular, the
mechanisms of how the vesicular neurotransmitter transporters
operate and utilize the proton electrochemical gradient,
as well as how Cl− and other ions directly or indirectly
modulate the transport activities have been enigmatic and
controversial. One problem that has hampered the complete
understanding of the transport systems is the lack of techniques
to quantitatively manipulate the H+ electrochemical gradient
that drives the transport. Recent technical developments,
including a chimeric protein named pHoenix that allows
light-driven H+ pumping (Rost et al., 2015) and the optimal
pH probe for SV pH measurement (Egashira et al., 2015),
may help to solve some of the issues discussed in this
review.
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